An Intrinsic Capacity Identification and Management Programme for Older Adults in Singapore's Primary Care

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-100
SponsorGeriatric Education and Research Institute

About this trial

The IMPACTFrail program is an intrinsic capacity (IC) identification and management program for mildly frail older adults. Specifically, it delivers the three-tier approach recommended in the National Frailty Strategy Policy Report. The program's core functions include the segmentation of older persons using the Clinical Frailty Scale (CFS) score followed by secondary IC screening for CFS 4 to 5 (Tier 1), follow-up clinical assessment to confirm IC losses (Tier 2) and needs-directed management and tracking of their health (Tier 3).

The investigator aims to conduct a multi-site feasibility study on a small group of older adult study participants (n=30 per polyclinic).

The feasibility study has a few components. First, a qualitative study will assess its feasibility (implementation, appropriateness, acceptability, practicality, adaptability) as perceived by older adults, healthcare providers, and healthcare administrators. Second, the investigator aims to collect process indicators to track its implementation progress. Third, program costs will be estimated. Fourth, the investigator will develop a logic model and theory of change, and cluster-specific detailed written program descriptions. Lastly, the investigator aims to triangulate the findings and assess the feasibility for larger-scale implementation. This study is guided by implementation science frameworks and guidelines for conducting feasibility studies.

Eligibility criteria

Qualifiers

being a patient of the polyclinic site

aged 60 years and above

Clinical frailty score (CFS) of 4 - 5

Not done comprehensive geriatric assessment (CGA) in the past 12 months (based on available medical records or self-report)

Disqualifiers

Do not meet inclusion criteria above

aged 21 years and above

Involved in the IMPACTFrail program as an implementer and/or a healthcare administrator with authority to make implementation decisions.

Do not meet inclusion criteria above

Trial design

Treatments tested in this trial

  • The IMPACTFrail programme

Treatment groups

180 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Geriatric Education and Research Institute

Lead sponsor

National Healthcare Group Polyclinics

Collaborator

National University Polyclinics

Collaborator

SingHealth Polyclinics

Collaborator